Company Summary
IP INTER PHARMA PUBLIC COMPANY LIMITED
Consumer Products
mai
CG Report:   
 
  Data as of 22 Jan 2021  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
16.80 18.00 / 3.68 55.86 7.42 103.00 3,460.80 3,238.21 70.53 35.97
News
Date/Time Subject
21 Jan 2021 20:05   Report on the utilization of capital increased from initial public offering
08 Jan 2021 17:42   List of securities which fulfilled the market surveillance criteria
07 Jan 2021 12:30   Notification on the Establishment of a New Joint Venture Company
30 Nov 2020 09:09   Notification of the Progress of the Acquisition of Modern Pharma Co., Ltd.
18 Nov 2020 17:03   Invitation for Shareholders to propose Agenda in advance for the 2021 Annual General Meeting, Candidates in the Election of the Company's Directors and questions at the Meeting.
more

Company Profile
Address 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong Sub-District, Bang Rak District Bangkok 10500
Telephone 0-2634-0225
Fax 0-2634-0135
URL www.interpharma.co.th
Establish Date - Listed Date 05/11/2019
IPO Price (Baht) 7.00 @Par0.50 Baht
IPO Financial Advisory
  • ADVISORY PLUS CO., LTD.
    		•
    Par 0.50 Baht
    Last Par Change N/A

    Business
    Research & development and distribution of healthcare products and aesthetic innovation products for human including health products for pets and livestock animals

    Free Float 10 Mar 2020 01 Nov 2019
    % /Shareholders
    42.66% 1,208 48.88% 846
    Foreign Shareholders 6.12% (As of 22/01/2021) Foreign Limit 49.00%
    NVDR Shareholders  1.65% (As of 22/01/2021)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Industry (%) Compare to Market (%)
    5 Days -1.18 1.26 -1.42
    20 Days 29.23 17.53 20.92
    60 Days 48.67 25.82 30.93
    120 Days 50.00 27.44 30.17
    YTD 28.24 21.62 23.10
    P/E (X) 55.86 27.94 76.81
    P/BV (X) 7.42 2.38 1.81
    Turnover Ratio (%) 0.59 0.56 0.32

    Top 10 Major Shareholders(@25 Jun 2020) Share %
    1. นาย ทรงวุฒิ ศักดิ์ชลาธร 102,852,300 49.93
    2. นาย PILIYARUTCH PHATRAKITKASEM 14,200,000 6.89
    3. MR. THAMRONGCHAI EAKAMORNWONG 5,977,200 2.90
    4. MISS PIMPATRA SUPHATCHARAWONG 5,836,600 2.83
    5. นาย ภาววิทย์ กลิ่นประทุม 5,376,600 2.61
    6. นาย วิทยา เทพนิมิตร 3,917,100 1.90
    7. MR. PICHIT CHINVITTAYAKUL 1,700,000 0.83
    8. บริษัท Thai NVDR Company Limited 1,492,612 0.72
    9. MR. PANIANG PONGSATHA 1,350,000 0.66
    10. MR. VICHAPHAN HEMRUNGROJN 1,050,000 0.51

    Management Position
    1. Mr. UDOM KACHINTORN CHAIRMAN OF THE BOARD / INDEPENDENT DIRECTOR
    2. Mr. TRINNAWAT THANITNITHIPHAN CHIEF EXECUTIVE OFFICER / DIRECTOR
    3. Miss SUPAPORN RERKPITAKPANICH DIRECTOR
    4. Miss NAPAPORN DECHAKARAT DIRECTOR
    5. Mr. PIYAMITR SRITARA INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
    6. Mr. AMORNSAKDI KETCHAROON INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    7. Mrs. SANSANEE CHAIYAROJ INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    22 Jan 2021    		 2020
    30 Dec 2020    		 2019
    30 Dec 2019
    Listed share (M.) 206.00  206.00  206.00 
    Market Cap (MB.) 3,460.80  2,698.60  1,308.10 
    Price (B./share) 16.80  13.10  6.35 
    BVPS (B./Share) 2.26  2.26  N/A 
    P/BV (X) 7.42  5.78  - 
    P/E (X) 55.86  43.56  46.58 
    Turnover Ratio (%) 27.61  294.49  193.16 
    Value Trade/Day (MB.) 57.81  26.18  90.03 
    Beta 1.68  1.71  - 
     
    Rate of Return YTD  2020  2019 
    Price Change (%) 28.24  106.30  -9.29 
    Dividend Yield (%) 1.10  1.41  N/A 
    Payout Ratio 0.62  0.62  - 
    Dividend Policy Not less than 50% of net profit after deduction of income tax and all types of reserves required by laws according to the separate financial statements of the Company or its subsidiaries (as the case may be) (with additional conditions)

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    01 Jan 2019 - 31 Dec 2019 0.185 Baht 27 Apr 2020 Cash
     
    Auditor
    (Effective Until 31/12/2020)
    MR. THANAWUT PIBOONSAWAT/DHARMNITI AUDITING CO., LTD.
    MISS SULALIT ARDSAWANG/DHARMNITI AUDITING CO., LTD.
    Miss POTJANARAT SIRIPIPAT/DHARMNITI AUDITING CO., LTD.
    Miss ROONGNAPHA SAENGCHAN/DHARMNITI AUDITING CO., LTD.
    		F/S Year ended 31/12
    Latest Type of Report Unqualified opinion
    Financial Data
    Statement of Financial Position (MB.) 9M/2020 
    (01/01/20 
    -30/09/20)     		 9M/2019 
    (01/01/19 
    -30/09/19)     		 2019 
    (01/01/19 
    -31/12/19)     		 2018 
    (01/01/18 
    -31/12/18) 
    Cash 319.42 26.02 342.65 32.45
    A/R Net 163.12 105.86 111.53 84.14
    Inventories 53.52 61.62 50.26 54.07
    Current Assets 536.82 197.49 505.05 172.47
    PP&E Net 15.25 10.06 9.67 10.74
    Total Assets 563.39 218.45 525.88 192.15
    OD - - - -
    A/P Net 56.18 47.69 38.25 64.48
    Current portion of LT 0.68 - - -
    Current Liabilities 74.54 73.23 56.23 83.85
    Non-Current Liabilities 7.92 1.82 3.91 1.31
    Total Liabilities 82.45 75.05 60.13 85.16
    Authorized Capital 103.00 103.00 103.00 65.00
    Paid-Up Capital 103.00 80.00 103.00 65.00
    Premium (Discount) on Share Capital 286.71 - 286.71 -
    Other Surplus (Deficit) 21.98 21.98 21.98 21.98
    Retained Earnings (Deficit) 54.88 32.77 44.02 13.57
    Treasury Stock - - - -
    Shareholders' Equity 466.56 134.75 455.71 100.55
    Minority Interest 14.37 8.65 10.03 6.44
    more
    Statement of Comprehensive Income (MB.) 9M/2020 
    (01/01/20 
    -30/09/20)     		 9M/2019 
    (01/01/19 
    -30/09/19)     		 2019 
    (01/01/19 
    -31/12/19)     		 2018 
    (01/01/18 
    -31/12/18) 
    Sales 306.75 274.53 371.33 313.64
    Other Income 4.04 3.78 4.56 0.75
    Total Revenues 310.78 278.30 375.88 314.40
    COGs 119.39 117.60 157.39 125.04
    SG&A 122.98 117.92 156.73 148.39
    Total Expenses 242.52 235.70 314.34 274.08
    EBITDA 70.53 44.12 63.61 42.16
    Depre. & Amor. 2.27 1.52 2.07 1.85
    EBIT 68.26 42.60 61.54 40.31
    Net Profit 49.25 30.77 43.47 29.68
    EPS (B.) 0.24 0.21 0.28 53.17
    more
    Statement of Cash Flow (MB.) 9M/2020 
    (01/01/20 
    -30/09/20)     		 9M/2019 
    (01/01/19 
    -30/09/19)     		 2019 
    (01/01/19 
    -31/12/19)     		 2018 
    (01/01/18 
    -31/12/18) 
    Operating Cash Flow 28.95 -14.11 5.03 -6.19
    Investing Cash Flow -14.67 -2.01 -2.05 -7.58
    Financing Cash Flow -37.51 9.68 307.21 10.14
    Net Cash Flow -23.23 -6.43 310.20 -3.63
    more
    Annualized: ROE, ROA
    Ratios 9M/2020  2019 
    Current Ratio (X) 7.20 8.98
    ROE (%) 20.61 15.63
    ROA (%) 22.31 17.14
    D/E (X) 0.18 0.13
    Total Asset Turnover (X) 1.04 1.05
    Gross Profit Margin (%) 61.08 57.61
    EBIT Margin (%) 21.96 16.37
    Net Profit Margin (%) 15.85 11.57

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 9M/2020  2019 
    Sales Growth N/A N/A
    COGs Growth N/A N/A
    Total Revenue Growth N/A N/A
    Total Expense Growth N/A N/A
    Net Profit Growth N/A N/A

    Annualized
    Cash Cycle 9M/2020  2019 
    A/R Turnover (Times) 3.00 3.80
    Avg. Collection Period (Days) 121.64 96.17
    Inventory Turnover (Times) 2.76 3.02
    Avg. Inventory Period (Days) 132.02 120.98
    A/P Turnover (Times) 3.06 3.06
    Avg. Payment Period (Days) 119.09 119.12
    Cash Cycle (Days) 134.57 98.02


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    Cash Balance 11 Jan 2021 - 19 Feb 2021
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name -

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
         		 Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The Information is provided for informative and educational purposes only.